- Home
- APGE vs ENVA Comparison
APGE vs ENVA Comparison
Compare APGE & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- ENVA
- Stock Information
- Founded
- APGE 2022
- ENVA 2011
- Country
- APGE United States
- ENVA United States
- Employees
- APGE N/A
- ENVA N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- ENVA Finance: Consumer Services
- Sector
- APGE Health Care
- ENVA Finance
- Exchange
- APGE Nasdaq
- ENVA Nasdaq
- Market Cap
- APGE 2.1B
- ENVA 2.4B
- IPO Year
- APGE 2023
- ENVA N/A
- Fundamental
- Price
- APGE $33.11
- ENVA $91.30
- Analyst Decision
- APGE Strong Buy
- ENVA Buy
- Analyst Count
- APGE 4
- ENVA 7
- Target Price
- APGE $91.33
- ENVA $116.00
- AVG Volume (30 Days)
- APGE 802.7K
- ENVA 304.8K
- Earning Date
- APGE 05-12-2025
- ENVA 04-29-2025
- Dividend Yield
- APGE N/A
- ENVA N/A
- EPS Growth
- APGE N/A
- ENVA 35.34
- EPS
- APGE N/A
- ENVA 7.43
- Revenue
- APGE N/A
- ENVA $1,239,007,000.00
- Revenue This Year
- APGE N/A
- ENVA $155.12
- Revenue Next Year
- APGE $743.14
- ENVA $13.07
- P/E Ratio
- APGE N/A
- ENVA $12.29
- Revenue Growth
- APGE N/A
- ENVA 19.69
- 52 Week Low
- APGE $26.20
- ENVA $57.46
- 52 Week High
- APGE $63.50
- ENVA $117.56
- Technical
- Relative Strength Index (RSI)
- APGE 45.63
- ENVA 45.94
- Support Level
- APGE $31.38
- ENVA $89.93
- Resistance Level
- APGE $34.23
- ENVA $93.52
- Average True Range (ATR)
- APGE 3.28
- ENVA 5.52
- MACD
- APGE -0.18
- ENVA 0.02
- Stochastic Oscillator
- APGE 54.22
- ENVA 48.30
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About ENVA Enova International Inc.
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.